VRTX Financials
Vertex Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$496.83
Market Cap
$121.95B
P/E Ratio
31.3
EPS
$15.32
Income Statement Highlights
Most Recent Quarter: FY
Revenue
$12.00B
Gross Profit
$10.35B
Operating Income
$4.17B
Net Income
$3.95B
EPS (Diluted)
$15.32
Balance Sheet Highlights
Total Assets
$25.64B
Total Liabilities
$6.98B
Shareholders Equity
$18.67B
Cash & Equivalents
$5.08B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$3.63B
CapEx
$437.60M
Free Cash Flow
$4.07B
Profitability Metrics
Gross Margin
53.7%
Operating Margin
0.4%
Net Margin
0.3%
ROE
0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is VRTX revenue?
VRTX's most recent quarterly revenue was $12.00B. Annual revenue can be calculated by summing the four most recent quarters.
Is VRTX profitable?
VRTX reported a profit of $3.95B in the most recent quarter. The net profit margin is 0.3%.
What is VRTX market cap?
VRTX has a market capitalization of $121.95B, making it a large-cap stock.
Does VRTX have debt?
View VRTX's balance sheet for debt information.
What is VRTX cash flow?
VRTX's most recent quarterly free cash flow was $4.07B.